Marival Bermejo

Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification

Nehal A. Kasim, Marc Whitehouse, Chandrasekharan Ramachandran et al. · Molecular Pharmaceutics · 2003 · 844 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan

Toshihide Takagi, Chandrasekharan Ramachandran, Marival Bermejo et al. · Molecular Pharmaceutics · 2006 · 597 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B Coculture Models To Predict Intestinal and Colonic Permeability Compared to Caco-2 Monoculture

Isabel Lozoya-Agulló, Francisca Araújo, Isabel González‐Álvarez et al. · Molecular Pharmaceutics · 2017 · 208 citations

Pharmacy, Pharmacology, Bioavailability +15

PAMPA—a drug absorption in vitro model

Marival Bermejo, Alex Avdeef, Ana Ruiz-Garcı́a et al. · European Journal of Pharmaceutical Sciences · 2004 · 205 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for <i>in Vivo</i> Dissolution and Absorption of Ionizable Drugs

Bart Hens, Yasuhiro Tsume, Marival Bermejo et al. · Molecular Pharmaceutics · 2017 · 130 citations

Pharmacy, Pharmacokinetics, Pharmacology +17